Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date
September 12, 2023
Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)
September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin…
Read More
The global interventional cardiology device market is driven by the number of procedures performed across the globe
By Emily Gilbert and Kamran Zamanian, PhD
September 12, 2023
The New Interventional Cardiology Market
The global interventional cardiology device market is driven by the number of procedures performed across the globe.…
Read More
UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality
September 12, 2023
UCLA Research Suggests that Heart Transplantation is Safer for Adults with Single-ventricle CHD than Previously Thought
September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients,…
Read More
Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL
September 12, 2023
American College of Cardiology Program to Increase Cholesterol Screenings
September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is…
Read More
Premier cardiovascular digital health experience continues cultivating a community to examine and solve for future complex healthcare needs
September 11, 2023
HRX 2023 Conference Propelling the Future of Digital Health
September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing…
Read More
The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR
September 11, 2023
MedAlliance Announces Enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study
September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease…
Read More
Regulatory and quality leader brings decades of global SaMD experience to guide leading AI-powered cardiovascular diagnostic company through growth and expansion
September 11, 2023
Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management
September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging…
Read More
the Company is exploring development of a new Phase III clinical trial protocol
September 08, 2023
BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
MPROVE-ISCHEMIA, a randomized, placebo-controlled trial, with topline data expected in 4Q 2023
September 08, 2023
Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISCHEMIA Clinical Trial of Ninerafaxstat in Patients with Stable Angina
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing…
Read More
Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically actionable variants in DCM genes than those of European ancestry
September 08, 2023
Study Highlights Need for Diversity in Clinical Trials to Better Understand, Treat Inherited Heart Muscle Disease
September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically…
Read More
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety
September 07, 2023
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval…
Read More
Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council
September 07, 2023
Faulkner to be Honored by American Heart Association
September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular…
Read More
Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension
September 07, 2023
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that…
Read More
Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap, which were designed to improve ablation outcomes and procedural efficiencies.
September 07, 2023
Vektor Medical Announces Enhanced AI-based vMap for Improved Cardiac Ablation Outcomes, Non-Invasive Mapping of Cardiac Arrhythmias
September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead…
Read More
Annual Scientific Symposium will take place October 23-26 in San Francisco
September 06, 2023
CRF Announces TCT 2023 Late-breaking Clinical Trials
September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical…
Read More
The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows
September 06, 2023
Large Kaiser Permanente Study Could Lead to Better Management for Patients with Aortic Stenosis
September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser…
Read More
Updated AI-based software is designed to improve cardiac ablation outcomes and procedural efficiencies
September 06, 2023
Vektor Medical Unveils Enhanced vMap Technology for Accurate, Non-invasive Mapping of Cardiac Arrhythmias
September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead …
Read More
Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.
September 06, 2023
Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump
September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device…
Read More
GE HealthCare and Mass General Brigham have announced the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity.
September 06, 2023
Mass Gen Brigham and GE HealthCare Collaboration Announces AI Algorithm, Radiology Operations Module (ROM), to Optimize Scheduling and Productivity
September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co…
Read More
Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.
September 05, 2023
Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released
September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now